Regulus Therapeutics Inc. - RGLS Net Assets per Single Share

Graphic logo of Regulus Therapeutics (RGLS)

The published book value of the share in the GURU.Markets system contains data where the 1.04 indicator determines this level. Regulus Therapeutics (RGLS) develops cutting-edge microRNA-based medicines for kidney treatment. However, intense competition and the risks of clinical trial failures create significant challenges. Stable management is successfully raising capital, adapting the strategy to new research phases.

Regulus Therapeutics Inc (RGLS) Equity per Share: for the period 07/04/2022 - 07/05/2025

regulusrx.com - analytical breakdowns and key metrics (RGLS)

Key analytical indicators for Regulus Therapeutics Inc. (RGLS):
Price Chart Regulus Therapeutics Inc|RGLS - Price Target Chart|Market Value Regulus Therapeutics Inc.|RGLS - Company Buyout Price|Book Value per Share Regulus Therapeutics|RGLS - Accounting Capitalization|Market Value to Book Value Ratio regulusrx.com|RGLS - Total Business Assets|Total Debt to Capital Regulus Therapeutics|RGLS - Long-Term Debt to Capital|Short-Term Debt to Equity Regulus Therapeutics Inc.|RGLS - Aggregate Debt Obligations|Debts to Book Capitalization Regulus Therapeutics Inc.
Analysis of all company metrics:Regulus Therapeutics Inc, RGLS
Manufactured products of Regulus Therapeutics Inc.

Professional capital evaluates Regulus Therapeutics (RGLS) through the lens of intellectual property capitalization for RNA therapeutics and strict regulatory oversight. The dynamics of the net book value per share reflect the remaining equity after deducting all liabilities, allowing investors to compare actual asset growth with management's ambitions and determine the fundamental stability of the biopharmaceutical asset.

Competitors of Regulus Therapeutics (RGLS)

TEM - Net Assets per Single Share|QGEN: Net Assets per Single Share|Ionis Pharmaceuticals - Net Assets per Single Share|repligen.com (RGEN) - Net Assets per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share Twist Bioscience, Inc. (TWST)|TXG - Accounting Value of a Share|Book Value per Share NTLA|Stoke Corp (STOK) - Net Asset Value per Share|BioLife Solutions, Inc. - Book Value per Share|Book Value of One Share wavelifesciences.com (WVE)|Accounting Value per Share MAZE|Book Value per Share SION (Sionna Therapeutics, Inc.)|Net Assets per Single Share Prime Medicine Corp PRME|TSHA - Net Assets per Single Share|uniQure N.V. - Accounting Value per Share|MGTX: Book Value per Share|REGENXBIO - Net Assets per Single Share|Net Assets per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp (PACB)|Accounting Value per Share Benitec Biopharma Inc.|Book Price of a Share designtx.com (DSGN)|Book Value per Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|LXEO (Lexeo) - Book Value per Share|KRRO: Net Asset Value per Share|Net Assets per Single Share Editas Medicine, Inc. EDIT|silence-therapeutics.com (SLN) - Accounting Value of a Share|PRQR (ProQR) - Book Value per Share|Book Value per Share CDXS|SGMO - Net Assets per Single Share|Share Book Value nautilus.bio (NAUT)|MGX: Book Value per Share|DTIL - Net Asset Value per Share|Generation Bio Corp - Accounting Value per Share|Boundless Bio Inc. (BOLD) - Book Value per Share|XCUR - Accounting Value per Share|Imunon (IMNN) - Book Price of a Share|PHIO: Book Value per Share|Net Assets per Share Mustang Bio Corp|Book Value per Share RNAZ (TransCode Therapeutics)|Accounting Value per Share BNGO (bionanogenomics.com)|Net Assets per Single Share APDN|bluebird bio, Inc - Net Assets per Share|Net Assets per Single Share ImmunoPrecise (IPA)|OMGA - Accounting Value of a Share|Book Value per Share OMIC (Singular Genomics)|SYRS (Syros Pharmaceuticals Inc.) - Book Value of One Share|Net Assets per Single Share Codex DNA|Net Assets per Single Share TCON|UBX (Unity Biotechnology) - Net Assets per Single Share